As of 2024-12-15, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is (0.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.53 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -115.7%.
The range of the Relative Valuation is (0.53) - (0.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.4x - 48.8x | 41.6x |
| Forward P/E multiples | 19.4x - 41.8x | 30.6x |
| Fair Price | (0.53) - (0.64) | (0.56) |
| Upside | -115.0% - -118.2% | -115.7% |
| Date | P/E |
| 2024-12-13 | -229.36 |
| 2024-12-12 | -231.31 |
| 2024-12-11 | -239.75 |
| 2024-12-10 | -241.70 |
| 2024-12-09 | -258.59 |
| 2024-12-06 | -222.86 |
| 2024-12-05 | -217.01 |
| 2024-12-04 | -230.66 |
| 2024-12-03 | -230.01 |
| 2024-12-02 | -235.20 |
| 2024-11-29 | -228.71 |
| 2024-11-27 | -238.45 |
| 2024-11-26 | -228.71 |
| 2024-11-25 | -217.66 |
| 2024-11-22 | -223.51 |
| 2024-11-21 | -217.01 |
| 2024-11-20 | -228.71 |
| 2024-11-19 | -247.55 |
| 2024-11-18 | -261.19 |
| 2024-11-15 | -273.54 |
| 2024-11-14 | -267.04 |
| 2024-11-13 | -279.71 |
| 2024-11-12 | -285.56 |
| 2024-11-11 | -310.57 |
| 2024-11-08 | -322.27 |
| 2024-11-07 | -302.78 |
| 2024-11-06 | -327.47 |
| 2024-11-05 | -291.73 |
| 2024-11-04 | -272.24 |
| 2024-11-01 | -272.24 |
| 2024-10-31 | -256.65 |
| 2024-10-30 | -269.64 |
| 2024-10-29 | -276.14 |
| 2024-10-28 | -269.64 |
| 2024-10-25 | -257.30 |
| 2024-10-24 | -258.59 |
| 2024-10-23 | -258.59 |
| 2024-10-22 | -265.09 |
| 2024-10-21 | -272.24 |
| 2024-10-18 | -285.88 |
| 2024-10-17 | -288.48 |
| 2024-10-16 | -292.38 |
| 2024-10-15 | -285.23 |
| 2024-10-14 | -278.74 |
| 2024-10-11 | -276.79 |
| 2024-10-10 | -273.54 |
| 2024-10-09 | -273.54 |
| 2024-10-08 | -269.64 |
| 2024-10-07 | -260.54 |
| 2024-10-04 | -279.39 |